CanImGuide continues to develop successfully and is pleased to announce that Johan Drott has been engaged to lead the company into the next phase. Johan Drott has more than 20 years’ experience in life science companies. He is CEO of Respiratorius AB since 2012 and of Diaprost AB since 2015, and both these assignments will remain unchanged. He has significant experience in commercial development of drug candidates within oncology and recently signed a Research and Option Agreement with a leading Pharmaceutical company for Diaprost AB.
